| Description |
1 online resources : ill., figs., tables |
| Series |
McGraw-Hill's AccessMedicine |
|
McGraw-Hill's AccessMedicine.
|
| Contents |
Section I: General Principles -- Chapter 1: Drug Invention and the Pharmaceutical Industry -- Chapter 2: Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination -- Chapter 3: Pharmacodynamics: Molecular Mechanisms of Drug Action -- Chapter 4: Drug Toxicity and Poisoning -- Chapter 5: Membrane Transporters and Drug Response -- Chapter 6: Drug Metabolism -- Chapter 7: Pharmacogenetics -- Section II: Neuropharmacology -- Chapter 8: Neurotransmission: The Autonomic and Somatic Motor Nervous Systems -- Chapter 9: Muscarinic Receptor Agonists and Antagonists -- Chapter 10: Anticholinesterase Agents -- Chapter 11: Nicotine and Agents Acting at the Neuromuscular Junction and Autonomic Ganglia -- Chapter 12: Adrenergic Agonists and Antagonists -- Chapter 13: 5-Hydroxytryptamine (Serotonin) and Dopamine -- Chapter 14: Neurotransmission in the Central Nervous System -- Chapter 15: Drug Therapy of Depression and Anxiety Disorders -- Chapter 16: Pharmacotherapy of Psychosis and Mania -- Chapter 17: Pharmacotherapy of the Epilepsies -- Chapter 18: Treatment of Central Nervous System Degenerative Disorders -- Chapter 19: Hypnotics and Sedatives -- Chapter 20: Opioids, Analgesia, and Pain Management -- Chapter 21: General Anesthetics and Therapeutic Gases -- Chapter 22: Local Anesthetics -- Chapter 23: Ethanol -- Chapter 24: Drug Use Disorders and Addiction -- Section III: Modulation of Pulmonary, Renal, and Cardiovascular Function -- Chapter 25: Drugs Affecting Renal Excretory Function -- Chapter 26: Renin and Angiotensin -- Chapter 27: Treatment of Ischemic Heart Disease -- Chapter 28: Treatment of Hypertension -- Chapter 29: Therapy of Heart Failure -- Chapter 30: Antiarrhythmic Drugs -- Chapter 31: Treatment of Pulmonary Arterial Hypertension -- Chapter 32: Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs -- Chapter 33: Drug Therapy for Dyslipidemias -- Section IV: Inflammation, Immunomodulation, and Hematopoiesis -- Chapter 34: Introduction to Immunity and Inflammation -- Chapter 35: Immunosuppressants and Tolerogens -- Chapter 36: Immune Globulins and Vaccines -- Chapter 37: Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor -- Chapter 38: Pharmacotherapy of Inflammation, Fever, Pain, and Gout -- Chapter 39: Histamine, Bradykinin, and Their Antagonists -- Chapter 40: Pulmonary Pharmacology -- Chapter 41: Hematopoietic Agents: Growth Factors, Minerals, and Vitamins -- Section V: Hormones and Hormone Antagonists -- Chapter 42: Introduction to Endocrinology: The Hypothalamic-Pituitary Axis -- Chapter 43: Thyroid and Antithyroid Drugs -- Chapter 44: Estrogens, Progestins, and the Female Reproductive Tract -- Chapter 45: Androgens and the Male Reproductive Tract -- Chapter 46: Adrenocorticotropic Hormone, Adrenal Steroids, and the Adrenal Cortex -- Chapter 47: Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia -- Chapter 48: Agents Affecting Mineral Ion Homeostasis and Bone Turnover -- Section VI: Gastrointestinal Pharmacology -- Chapter 49: Pharmacotherapy for Gastric Acidity, Peptic Ulcers, and Gastroesophageal Reflux Disease -- Chapter 50: Gastrointestinal Motility and Water Flux, Emesis, and Biliary and Pancreatic Disease -- Chapter 51: Pharmacotherapy of Inflammatory Bowel Disease -- Section VII: Chemotherapy of Infectious Diseases |
|
Chapter 52: General Principles of Antimicrobial Therapy -- Chapter 53: Chemotherapy of Malaria -- Chapter 54: Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections -- Chapter 55: Chemotherapy of Helminth Infections -- Chapter 56: Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections -- Chapter 57: Penicillins, Cephalosporins, and Other β-Lactam Antibiotics -- Chapter 58: Aminoglycosides -- Chapter 59: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents -- Chapter 60: Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy -- Chapter 61: Antifungal Agents -- Chapter 62: Antiviral Agents (Nonretroviral) -- Chapter 63: Treatment of Viral Hepatitis (HBV/HCV) -- Chapter 64: Antiretroviral Agents and Treatment of HIV Infection -- Section VIII: Pharmacotherapy of Neoplastic Disease -- Chapter 65: General Principles in the Pharmacotherapy of Cancer -- Chapter 66: Cytotoxic Drugs -- Chapter 67: Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules -- Chapter 68: Hormones and Related Agents in the Therapy of Cancer -- Section IX: Special Systems Pharmacology -- Chapter 69: Ocular Pharmacology -- Chapter 70: Dermatological Pharmacology -- Chapter 71: Environmental Toxicology: Carcinogens and Heavy Metals -- Appendices -- Appendix I: Principles of Prescription Order Writing and Patient Compliance -- Appendix II: Design and Optimization of Dosage Regimens: Pharmacokinetic Data |
| Bibliography |
Includes bibliographical references and indexes |
| Notes |
Also issued in Online and PDF version |
|
Description based on cover image and table of contents, viewed on Aug. 16, 2017 |
| Subject |
Pharmacological Phenomena
|
|
Pharmaceutical Preparations
|
|
Pharmacokinetics.
|
|
Drug Therapy
|
|
Pharmacology.
|
|
Therapeutics.
|
|
Drug Therapy.
|
|
Pharmaceutical Preparations.
|
|
Pharmacokinetics.
|
|
Pharmacological Phenomena.
|
| Form |
Electronic book
|
| Author |
Brunton, Laurence L., ed.
|
|
Knollmann, Björn C., ed.
|
|
Hilal-Dandan, Randa, ed.
|
| LC no. |
2017031869 |
| ISBN |
9781259584732 (print-ISBN) |
|
1259584739 (print-ISBN) |
|
